Olon S.p.A. is a worldwide leader in the development and production of APIs (Active Pharmaceutical Ingredients).
The ideal partner for custom synthesis and contract manufacturing projects.

NEWS & EVENTS

CPHI Worldwide in Madrid


9-11 October 2018 - Also this year, Olon will be attending the CPHI Worldwide in Madrid. Please visit our booth: 7C10.

Olon on Pharma’s Almanac Magazine


May 2018

Strengthening the outsource service offering through integration...Click the image to read the full article

Olon Announces Investment and Expansion of APIs Manufacturing Capabilities


January 2018

Rodano, Italy – January 26th, 2018 – Between 2016 and 2017, Olon SpA, European leader of API manufacturing, invested more than 10 million € to expand...

READ MORE

OLON’S COMMITMENT IN ENERGY EFFICIENCY


December 06th, 2017

For several years Olon Settimo Torinese plant has been a partner in supplying thermal energy to the urban community heating network of Settimo Torinese...

READ MORE

Olon on Pharma Horizon Magazine


October 2017

Not just a telling story... Click the image to read the full article.

OLON acquired RICERCA


June 9th, 2017

OLON SPA (P&R Group) ACQUIRES RICERCA BIOSCIENCES CHEMICAL DIVISION IN OHIO (USA). Acquisition strengthens service offering of global CDMO and Generics provider...

READ MORE
If you need information, speak to one our experts.

FOCUS ON

Recombinant peptides

Olon has developed a recombinant peptide technology that allows to provide its customers with requested peptide on any scale.

Fluorination: a new technology

Olon with its brand new R&D Labs and Reactors for fluorination can now offer a full range of fluorinating processes under cGMP.